Cargando…
BRG1 is a biomarker of hypertrophic cardiomyopathy in human heart specimens
Hypertrophic cardiomyopathy (HCM) is a genetic disease of the sarcomere that causes otherwise unexplained cardiac hypertrophy and is associated with sudden death. While previous studies showed the role of the epigenetic modifier Brg1 in mouse models of HCM, additional work is needed to identify its...
Autores principales: | Scherba, Jacob C., Halushka, Marc K., Andersen, Nicholas D., Maleszewski, Joseph J., Landstrom, Andrew P., Bursac, Nenad, Glass, Carolyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114001/ https://www.ncbi.nlm.nih.gov/pubmed/35581268 http://dx.doi.org/10.1038/s41598-022-11829-x |
Ejemplares similares
-
The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
por: Noureldin, Radwa A, et al.
Publicado: (2012) -
Circulating Biomarkers in Hypertrophic Cardiomyopathy
por: Matthia, Eldon L., et al.
Publicado: (2022) -
Heart transplantation in patients with hypertrophic cardiomyopathy
por: Torres, Marta Farrero, et al.
Publicado: (2018) -
Biomarkers of cardiovascular stress and fibrosis in preclinical hypertrophic cardiomyopathy
por: Ho, Jennifer E, et al.
Publicado: (2017) -
Heart Rate Recovery in Patients With Hypertrophic Cardiomyopathy
por: Patel, Vimal, et al.
Publicado: (2014)